Lung cancer is by far the most lethal form of cancer in the U.S., accounting for about 1 in 5 of all cancer deaths.
2d
AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans to launch its microRNA Signature ...
A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...
An independent data monitoring board found that BeiGene’s ociperlimab was unlikely to significantly boost overall survival in ...
On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell therapy, for the treatment of pediatric and adult patients with ...
Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...
New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...
In a new study that challenges long-held views on lung cancer, University of Kentucky Markey Cancer Center researchers have ...
Favorable initial results from a phase 1/2 trial of solnerstotug in PD-L1–resistant tumors showed a 14% response rate and 62% ...
The following is a summary of "Mediastinal staging lymph node probability map in non-small cell lung cancer,” published in the March 2025 issue of Respiratory Research by Bordas-Martinez et al.
The Hearty Soul on MSN9d
High-Sugar Diet Linked to Lung Cancer, Expanding Our Understanding of Diet's ImpactWe all know at this point that high-sugar diets are not good for us. They increase our risk of developing cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback